Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Mar. 31, 2026	Dec. 31, 2025
Statement of Financial Position [Abstract]
Allowance for accounts receivable	$ 120,089	$ 119,305
Allowance for notes receivable, current	27,696	25,931
Accumulated amortization for other intangible assets	43,580	42,931
Allowance for notes receivable, non current	$ 1,953	$ 1,776
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock authorized (in shares)	200,000,000	200,000,000
Common stock issued (in shares)	77,270,000	76,821,000
Common stock outstanding (in shares)	68,931,000	69,596,000
Common stock in treasury (in shares)	8,339,000	7,225,000